Rapafusyn Pharmaceuticals Funding: $44M Raised, Series A
Rapafusyn Pharmaceuticals is based in Baltimore. It has raised $44M in total funding. Latest round: Series A.
Rapafusyn Pharmaceuticals funding overview
Rapafusyn Pharmaceuticals is based in Baltimore. Rapafusyn Pharmaceuticals has raised $44M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2025. The round record for Rapafusyn Pharmaceuticals runs through 2025; nothing later has been disclosed. Investors on record include BioTrack Capital, Yonjin Capital, 3E Bioventures Capital, Proxima Ventures Ltd., Lapam Capital. 5 distinct backers are named across the disclosed rounds.
Rapafusyn Pharmaceuticals at a glance
Total raised
$44M
Latest round
Series A
Latest round date
September 2025
Headquarters
Baltimore
Notable investors
BioTrack Capital, Yonjin Capital, 3E Bioventures Capital, Proxima Ventures Ltd., Lapam Capital
Frequently asked about Rapafusyn Pharmaceuticals funding
How much has Rapafusyn Pharmaceuticals raised?
Rapafusyn Pharmaceuticals has raised $44M in total disclosed funding across the rounds on record.
Who has invested in Rapafusyn Pharmaceuticals?
BioTrack Capital, Yonjin Capital, 3E Bioventures Capital, Proxima Ventures Ltd., Lapam Capital are named among the investors backing Rapafusyn Pharmaceuticals.
What was the latest Rapafusyn Pharmaceuticals funding round?
The most recent disclosed round is a Series A, announced in September 2025.
Where is Rapafusyn Pharmaceuticals based?
Rapafusyn Pharmaceuticals is based in Baltimore.
When did Rapafusyn Pharmaceuticals last raise?
The last disclosed Rapafusyn Pharmaceuticals round closed in September 2025 at Series A.
We update the Rapafusyn Pharmaceuticals record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Baltimore and their backers are listed below.
Companies related to Rapafusyn Pharmaceuticals (36)
